CRBP shareholder plans sale of 17,000 shares

A shareholder of CRBP has notified an intention to sell 17,000 shares of common stock through Stifel Nicolaus & Company Inc. The proposed sale has an indicated value of $171,396.00 and is listed for trading on Nasdaq with a proposed sale date of 08/07/2026.

Rhea-AI Filing Summary

A shareholder of CRBP has notified an intention to sell 17,000 shares of common stock through Stifel Nicolaus & Company Inc. The proposed sale has an indicated value of $171,396.00 and is listed for trading on Nasdaq with a proposed sale date of 08/07/2026.

The planned sale is supported by equity awards consisting of restricted stock units granted as equity compensation, including 9,210 units dated 02/12/2025 and 7,790 units dated 01/31/2026.

Key Figures

Shares to be sold: 17,000 shares Aggregate value: $171,396.00 Proposed sale date: 08/07/2026 +2 more

5 metrics

Shares to be sold 17,000 shares Proposed sale of common stock through Stifel Nicolaus & Company Inc.

Aggregate value $171,396.00 Indicated value of the 17,000 common shares planned for sale

Proposed sale date 08/07/2026 Date associated with the proposed Nasdaq sale of common stock

RSUs grant 1 9,210 units Restricted stock units dated 02/12/2025 listed as equity compensation common stock

RSUs grant 2 7,790 units Restricted stock units dated 01/31/2026 listed as equity compensation common stock

Key Terms

Form 144, Restricted Stock Units, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Common Stock | 02/12/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Compensation financial

"9210 | 02/12/2025 | Equity Compensation Common Stock"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRBP common shares are planned for sale under this Form 144?

The shareholder plans to sell 17,000 shares of CRBP common stock. The proposed transaction is valued at $171,396.00 and is expected to be executed through Stifel Nicolaus & Company Inc. on 08/07/2026 on Nasdaq.

What is the indicated value of the CRBP shares to be sold?

The indicated value of the planned CRBP share sale is $171,396.00. This amount corresponds to the proposed sale of 17,000 common shares to be traded through Stifel Nicolaus & Company Inc. on Nasdaq.

Which broker is handling the proposed CRBP stock sale?

The proposed CRBP stock sale will be handled by Stifel Nicolaus & Company Inc.. The broker is listed for the planned disposition of 17,000 common shares with a stated value of $171,396.00 on 08/07/2026.

What equity awards support the CRBP Form 144 planned sale?

The planned sale is supported by restricted stock units granted as equity compensation. These include 9,210 units dated 02/12/2025 and 7,790 units dated 01/31/2026, both identified as equity compensation common stock.

On which exchange will the CRBP shares be sold?

The CRBP common shares covered by this Form 144 notice are listed for sale on Nasdaq. The filing specifies a proposed sale of 17,000 shares of common stock with an indicated value of $171,396.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:05 PM Accepted by SEC EDGAR 08/07/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972481
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corbus Pharmaceuticals Holdings, Inc.
SEC File Number	001-37348
Address of Issuer	500 RIVER RIDGE DRIVE NORWOOD MASSACHUSETTS 02062
Phone	617-963-0103
Name of Person for Whose Account the Securities are To Be Sold	Stifel, Nicolaus & Company, Inc CIAS /FA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	17000	171396.00	19341293	08/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/12/2025	Restricted Stock Units	Issuer			9210	02/12/2025	Equity Compensation
Common Stock	01/31/2026	Restricted Stock Units	Issuer			7790	01/31/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Azad Daswani, as a duly authorized representative of STIFEL, as attorney-in-fact for Yuval Cohen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)